Premium
Tissue microarray analysis reveals protein expression patterns and potential biomarkers of clinical benefit to bortezomib in relapsed/refractory non‐Hodgkin lymphoma
Author(s) -
Gerecitano John,
Gounder Sivaraman,
TeruyaFeldstein Julie,
Arcila Maria,
Ogilvie Shahiba,
Gonzalez Camille,
Lin Dorothy,
Zheng Junting,
Zhang Zhigang,
McDonald Alice,
Mulligan George,
O'Connor Owen A.
Publication year - 2012
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.2012.09137.x
Subject(s) - tissue microarray , bortezomib , follicular lymphoma , mantle cell lymphoma , medicine , cancer research , lymphoma , cyclin d1 , oncology , diffuse large b cell lymphoma , proteasome inhibitor , bcl6 , cancer , germinal center , cell cycle , pathology , immunology , b cell , antibody , multiple myeloma